Insider filing · UTHR
Paul A Mahon
EVP & GENERAL COUNSEL
profile →
United Therapeutics Corporation
UTHR · Healthcare · 343 filings in 24 months
ticker →
Paul A Mahon sold $5.3M of United Therapeutics (UTHR)
Executed Dec 11 2025, disclosed Dec 12 2025, 1 day later.
Value, as filed
$5.3M
11,000 sh across 6 lots
Executed
Dec 11 2025
the trade date, as filed
Disclosed
Dec 12 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PMPaul A Mahon (EVP & GENERAL COUNSEL) filed 24 Form 4 reports in the trailing twelve months (0 purchases, 24 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $5.5M of UTHR (10,742 sh across 4 lots, as filed), executed Dec 24 2025.
The name
UTHRHealthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Paul A Mahon in UTHR
UTHRSALE
United Therapeutics Corporation
$4.1M8,175 sh across 6 lots
Exec Sep 17
Filed Sep 18 · 4:40 PM ET UTHRSALE United Therapeutics Corporation $4.3M
8,180 sh across 8 lots
Exec Aug 20
Filed Aug 21 · 4:43 PM ET UTHRSALE United Therapeutics Corporation $4.3M
8,300 sh across 8 lots
Exec Aug 6
Filed Aug 6 · 4:35 PM ET UTHRSALE United Therapeutics Corporation $4.3M
8,100 sh across 6 lots
Exec Jul 16
Filed Jul 16 · 4:30 PM ET UTHRSALE United Therapeutics Corporation $4.6M
8,300 sh across 9 lots
Exec Jul 2
Filed Jul 2 · 4:32 PM ET UTHRSALE United Therapeutics Corporation $4.3M
7,983 sh across 9 lots
Exec Jun 18
Filed Jun 18 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $4.5M
8,300 sh across 8 lots
Exec Jun 4
Filed Jun 4 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $4.6M
8,180 sh across 8 lots
Exec May 21
Filed May 21 · 5:30 PM ET